naproxen has been researched along with Drug-Related Side Effects and Adverse Reactions in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (9.52) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 7 (33.33) | 29.6817 |
2010's | 11 (52.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Feo-Brito, F; Herreros, B; Méndez, Y; Urra, JM | 1 |
Husni, ME; Nissen, S; Paynter, N; Shao, M; Solomon, DH; Wolski, K | 1 |
Bramson, C; Brown, MT; Gimbel, JS; Keller, DS; Kivitz, AJ; Nemeth, MA; Verburg, KM; West, CR | 1 |
Choi, SJ; Ji, JD; Kim, JH; Lee, YH; Seo, YH; Song, GG | 1 |
Li, L | 1 |
Choy, EH; Gaugris, S; Jansen, JP; Nash, JT; Ostor, A; Stam, W | 1 |
Gunsch, CK; Wang, S | 1 |
Özkaya, E | 1 |
Breitner, JC; Green, RC; Lyketsos, CG; Martin, BK; Meinert, C; Piantadosi, S; Sabbagh, M | 1 |
Fraser, W; Garner, P; Krewski, D; Nimrod, C; Olatunbosun, O; Walker, MC; Wen, SW; Yang, Q; Yang, T | 1 |
Duque-Oliart, A; García-Rodríguez, LA; Pérez-Gutthann, S; Varas-Lorenzo, C | 1 |
Boyd, GR; Grimm, DA | 1 |
Fraunfelder, FT | 1 |
Achong, MR | 1 |
1 review(s) available for naproxen and Drug-Related Side Effects and Adverse Reactions
Article | Year |
---|---|
Relative efficacy and tolerability of etoricoxib, celecoxib, and naproxen in the treatment of osteoarthritis : A Bayesian network meta-analysis of randomized controlled trials based on patient withdrawal.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bayes Theorem; Celecoxib; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Etoricoxib; Female; Humans; Male; Middle Aged; Naproxen; Osteoarthritis; Outcome Assessment, Health Care; Proportional Hazards Models; Pyridines; Randomized Controlled Trials as Topic; Sulfones; Treatment Outcome | 2016 |
3 trial(s) available for naproxen and Drug-Related Side Effects and Adverse Reactions
Article | Year |
---|---|
Derivation and Validation of a Major Toxicity Risk Score Among Nonsteroidal Antiinflammatory Drug Users Based on Data From a Randomized Controlled Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cardiovascular Diseases; Celecoxib; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Ibuprofen; Male; Middle Aged; Naproxen; Osteoarthritis; Reproducibility of Results; Risk Assessment; Risk Factors | 2019 |
Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain.
Topics: Adolescent; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Chronic Pain; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Low Back Pain; Male; Middle Aged; Naproxen; Pain Measurement; Placebo Effect; Prevalence; Risk Factors; Treatment Outcome; United States; Young Adult | 2013 |
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.
Topics: Adult; Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Brain; Celecoxib; Cyclooxygenase Inhibitors; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Naproxen; Nootropic Agents; Patient Selection; Pyrazoles; Selection Bias; Sulfonamides; Treatment Failure; Treatment Outcome | 2007 |
17 other study(ies) available for naproxen and Drug-Related Side Effects and Adverse Reactions
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Usefulness of basophil activation test for the diagnosis of IgE mediated hypersensitivity to tetanus toxoid vaccine.
Topics: Aged, 80 and over; Allergens; Amoxicillin; Anaphylaxis; Basophils; Cell Degranulation; Cells, Cultured; Diagnosis, Differential; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Immunologic Tests; Male; Naproxen; Tetanus Toxoid; Wounds, Stab | 2018 |
A conditional sequential sampling procedure for drug safety surveillance.
Topics: Aged; Computer Simulation; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lactones; Male; Middle Aged; Myocardial Infarction; Naproxen; Product Surveillance, Postmarketing; Risk; Sulfones | 2009 |
Cost effectiveness of etoricoxib versus celecoxib and non-selective NSAIDS in the treatment of ankylosing spondylitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bayes Theorem; Celecoxib; Cost-Benefit Analysis; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Costs; Drug-Related Side Effects and Adverse Reactions; Etoricoxib; Humans; Markov Chains; Meta-Analysis as Topic; Models, Economic; Naproxen; Pyrazoles; Pyridines; Quality-Adjusted Life Years; Severity of Illness Index; Spondylitis, Ankylosing; Sulfonamides; Sulfones; Treatment Outcome; United Kingdom | 2010 |
Effects of selected pharmaceutically active compounds on treatment performance in sequencing batch reactors mimicking wastewater treatment plants operations.
Topics: Bacteria; Biodiversity; Bioreactors; Carbamazepine; Drug-Related Side Effects and Adverse Reactions; Gemfibrozil; Ketoprofen; Microbial Consortia; Naproxen; Pharmaceutical Preparations; Waste Disposal, Fluid; Water Microbiology; Water Pollutants, Chemical | 2011 |
Oral mucosal fixed drug eruption: characteristics and differential diagnosis.
Topics: Adolescent; Adult; Age Distribution; Behcet Syndrome; Child; Cross-Sectional Studies; Diagnosis, Differential; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Herpes Simplex; Humans; Incidence; Male; Middle Aged; Mouth Mucosa; Naproxen; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Distribution; Stomatitis, Aphthous; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2013 |
Lessons to learn from the COX-2 saga. Yes, FDA reforms are needed. And marketing distorts how medications are used. But one moral to the story is that all drugs have risks.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug-Related Side Effects and Adverse Reactions; Humans; Isoxazoles; Lactones; Marketing of Health Services; Naproxen; Pyrazoles; Risk Assessment; Sulfonamides; Sulfones; United States; United States Food and Drug Administration | 2005 |
Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population.
Topics: Adult; Albuterol; Contraceptives, Oral; Cross-Sectional Studies; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Female; Gestational Age; Humans; Ibuprofen; Infant, Newborn; Naproxen; Population Surveillance; Pregnancy; Prenatal Exposure Delayed Effects; Saskatchewan; Trimethoprim, Sulfamethoxazole Drug Combination; United States; United States Food and Drug Administration | 2008 |
Low-dose diclofenac, naproxen, and ibuprofen cohort study.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Cohort Studies; Diclofenac; Dose-Response Relationship, Drug; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Hemorrhage; Hematologic Diseases; Humans; Ibuprofen; Male; Middle Aged; Naproxen | 1999 |
Occurrence of pharmaceutical contaminants and screening of treatment alternatives for southeastern Louisiana.
Topics: Animals; Carbon; Clofibric Acid; Drug-Related Side Effects and Adverse Reactions; Environmental Monitoring; Estrone; Gas Chromatography-Mass Spectrometry; Louisiana; Naproxen; Thermodynamics; Water Pollutants, Chemical | 2001 |
Interim report: National Registry of Possible Drug-Induced Ocular Side Effects.
Topics: Aged; Anesthetics, Local; Carbonic Anhydrase Inhibitors; Cardiovascular Diseases; Diazepam; Dietary Proteins; Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Female; Fluorides, Topical; Humans; Infant; Middle Aged; Naproxen; Phenylephrine; Registries; Thiabendazole | 1979 |
When is a clinical event an adverse drug reaction?
Topics: Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Female; Fever; Humans; Middle Aged; Naproxen; Time Factors | 1978 |